Featured Research

from universities, journals, and other organizations

Infection risk not increased by use of antirheumatic drugs prior to surgery in patients with rheumatoid arthritis, study suggests

Date:
October 27, 2013
Source:
American College of Rheumatology (ACR)
Summary:
Patients with rheumatoid arthritis may not need to halt use of their antirheumatic drugs prior to surgery due to fears of increased infection risk, according to new research.

Patients with rheumatoid arthritis may not need to halt use of their antirheumatic drugs prior to surgery due to fears of increased infection risk, according to research presented this week at the American College of Rheumatology Annual Meeting in San Diego.

Related Articles


Rheumatoid arthritis is a chronic disease that causes pain, stiffness, swelling, and limitation in the motion and function of multiple joints. Though joints are the principal body parts affected by RA, inflammation can develop in other organs as well. An estimated 1.3 million Americans have RA, and the disease typically affects women twice as often as men.

Researchers based at the Michael E. DeBakey Veterans Affairs Medical Center and the Baylor College of Medicine in Houston, Tex., gathered data on perioperative use of disease-modifying antirheumatic drugs, such as methotrexate, and the subsequent rate of postoperative infections from RA patients treated in the VA Medical Center over a 10-year period from 2000 to 2009. While there was little evidence to support temporary stopping of DMARDs or biologic agents in RA patients prior to surgery, the common reasoning had been that the drugs may increase patients' infection risk due to their suppression of the immune system to control inflammation in autoimmune diseases like RA.

The researchers' aim was to examine postoperative infection rates in a sample of RA patients in order to determine if use of the immunosuppressant drugs prior to surgery had any effect on their infection risks 30 days after their procedures, says Bernard Ng, MD; associate professor of medicine and chief of rheumatology; VA Puget Sound HCS; and an investigator in the study.

"Our ability to make evidence-based recommendations on whether immunosuppressive drugs for treatment of RA should be stopped before an elective surgery is limited based on current literature on this topic," explains Dr. Ng. "We often receive consults from our surgery colleagues for this issue, and apart from certain orthopedic surgeries and the use of methotrexate, we don't really have much to say when other surgeries and DMARDs are involved."

Using VA administrative patient databases, the researchers looked at 6,548 RA patients who had been using only one DMARD or biologic agent in the perioperative period. Those patients using multiple agents were excluded to simplify the results. The researchers then compared the rate of wound infections within 30 days of surgery for these patients with the amount of time prior to surgery that their medication had been stopped. Wound infections, according to the modified 1992 U.S. Centers for Disease Control and Prevention criteria for postoperative infection, were recorded and analyzed by themselves and together with other infections like pneumonia, urinary tract infections and sepsis. Other factors that might also affect infection rates, such as co-existing diseases, diabetes mellitus, smoking or chronic steroid use, were also factored in by the researchers.

Results showed that RA patients who did not stop their use of a DMARD or biologic agent prior to surgery did not have a significantly higher risk of postoperative infection compared to patients who did stop their drugs. Conversely, those patients who stopped using their DMARD or biologic agent after surgery did have an increased incidence of both postoperative wound infections and general infections. Drug treatments likely were halted because the patients developed postoperative infections, the study authors concluded.

"Our results suggest that the likelihood of postoperative infections between those who discontinued RA medications before surgery and those who continued did not differ significantly. Thereby, suggesting that it may not be necessary for RA patients to discontinue these medications prior to elective surgeries. Indeed, continuing these medications may reduce the risk of RA flares that may result from stopping them," says Dr. Ng.

Dr. Ng goes on to say, "This is a preliminary database study with several limitations. For example, the analyses done involved only single DMARD and biologic use, and the types of surgeries were not categorized. Further studies analyzing various combinations of DMARD and biologics, and specific types of surgeries will be useful in helping us develop deeper knowledge in this area." Patients should talk to their rheumatologists to determine their best course of treatment.


Story Source:

The above story is based on materials provided by American College of Rheumatology (ACR). Note: Materials may be edited for content and length.


Cite This Page:

American College of Rheumatology (ACR). "Infection risk not increased by use of antirheumatic drugs prior to surgery in patients with rheumatoid arthritis, study suggests." ScienceDaily. ScienceDaily, 27 October 2013. <www.sciencedaily.com/releases/2013/10/131027122925.htm>.
American College of Rheumatology (ACR). (2013, October 27). Infection risk not increased by use of antirheumatic drugs prior to surgery in patients with rheumatoid arthritis, study suggests. ScienceDaily. Retrieved November 28, 2014 from www.sciencedaily.com/releases/2013/10/131027122925.htm
American College of Rheumatology (ACR). "Infection risk not increased by use of antirheumatic drugs prior to surgery in patients with rheumatoid arthritis, study suggests." ScienceDaily. www.sciencedaily.com/releases/2013/10/131027122925.htm (accessed November 28, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, November 28, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Rural India's Low-Cost Sanitary Pad Revolution

Rural India's Low-Cost Sanitary Pad Revolution

AFP (Nov. 28, 2014) — One man hopes his invention -– a machine that produces cheap sanitary pads –- will help empower Indian women. Duration: 01:51 Video provided by AFP
Powered by NewsLook.com
Research on Bats Could Help Develop Drugs Against Ebola

Research on Bats Could Help Develop Drugs Against Ebola

AFP (Nov. 28, 2014) — In Africa's only biosafety level 4 laboratory, scientists have been carrying out experiments on bats to understand how virus like Ebola are being transmitted, and how some of them resist to it. Duration: 01:18 Video provided by AFP
Powered by NewsLook.com
WHO Says Male Ebola Survivors Should Abstain From Sex

WHO Says Male Ebola Survivors Should Abstain From Sex

Newsy (Nov. 28, 2014) — WHO cites four studies that say Ebola can still be detected in semen up to 82 days after the onset of symptoms. Video provided by Newsy
Powered by NewsLook.com
Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins